ALPHAMAB ONCOLO.DL-000002 (3NK) — Free Cash Flow Generation Index

Latest as of December 2024: 0.90x

ALPHAMAB ONCOLO.DL-000002 (3NK) has a Free Cash Flow Generation Index of 0.90x as of December 2024. Free cash flow of €190.56 Million represents 1% of operating cash flow (€212.34 Million). Explore reinvestment intensity of ALPHAMAB ONCOLO.DL-000002 to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

0.90x

Free Cash Flow / Operating CF

Free Cash Flow

€190.56 Million

EUR

Operating Cash Flow

€212.34 Million

EUR

Capital Expenditures

€21.77 Million

EUR

ALPHAMAB ONCOLO.DL-000002 Free Cash Flow Generation Index (2024–2024)

Historical FCF Generation Index trend for ALPHAMAB ONCOLO.DL-000002 across 1 annual periods. For the full cash flow conversion analysis, see how efficiently does ALPHAMAB ONCOLO.DL-000002 generate cash.

Annual Free Cash Flow Generation for ALPHAMAB ONCOLO.DL-000002 (2024–2024)

Year-by-year Free Cash Flow Generation Index for ALPHAMAB ONCOLO.DL-000002. Check ALPHAMAB ONCOLO.DL-000002 (3NK) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Year	FCG Index	Free Cash Flow (EUR)	Operating CF	Capital Expenditures	YoY Change
2024	0.90x	€190.56 Million	€212.34 Million	€21.77 Million	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).